Roche Holding AG (0QOK.IL)
- Reuters
Roche launches new test to detect fast spreading Omicron sub-variant
Roche has launched a new PCR test to detect a fast-spreading sub-variant of the Omicron variant of Coronavirus, the Swiss drugmaker said on Thursday. The new test specifically targets the XBB.1.5 Omicron variant and will help researchers closely track the virus’s lineage and provide insights into the epidemiology and impact it has on public health, the company added. The XBB.1.5 variant is prevalent in the United States and is quickly spreading to other countries, Roche said.
- Globe Newswire
Roche launches COVID-19 PCR test to detect the fast spreading XBB.1.5 Omicron sub-variant
This new test for researchers specifically targets the XBB.1.5 Omicron sub-variant and runs on the real-time PCR platforms LightCycler® 480 II* and cobas® z480.Results from the test will help closely track the virus’ lineage and provide insights into the epidemiology and impact it has on public health.Concern from the World Health Organisation centres around the XBB.1.5 high transmissibility and growth advantage.1 Basel, 26 January 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) and its subsidiary TIB
- Zacks
Roche (RHHBY) Tecentriq Meets Adjuvant Liver Cancer Study Goal
Roche's (RHHBY) phase III IMbrave050 study, evaluating Tecentriq plus Avastin for treating early-stage hepatocellular carcinoma, meets its primary endpoint.
